Skip to main content

Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the second quarter of the fiscal year 2021.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.